Kestra Advisory Services, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1830819
AUSTIN, TX
Position in REGN
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$3,453,700
+$53,613 QoQ
Shares Held
4,470
+1.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kestra Advisory Services, LLC holds $25,439,677 across 48 Biotechnology names. REGN ranks #2 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,950 | $6,229,233 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,470 | $3,453,700 | |
| 3 | CELC |
Celcuity Inc.
|
13,604 | $1,552,760 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
21,052 | $1,001,443 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
39,901 | $987,948 | |
| 6 | RPRX |
Royalty Pharma plc
|
18,736 | $898,765 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
27,122 | $882,549 | |
| 8 | CING |
Cingulate Inc.
|
140,000 | $869,400 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,453,700 | 4,470 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,400,087 | 4,405 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,155,743 | 3,834 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,933,575 | 3,683 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,110,898 | 4,905 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,801,104 | 6,740 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,030,693 | 6,688 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,469,089 | 6,155 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,876,001 | 6,105 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,336,996 | 4,938 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,517,331 | 4,274 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,083,255 | 4,291 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,742,706 | 4,555 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,568,474 | 6,332 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,862,494 | 5,607 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $3,540,868 | 5,990 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,182,974 | 7,421 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $4,090,986 | 6,478 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $4,386,344 | 7,248 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $3,795,837 | 6,796 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $2,340,150 | 4,946 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $1,493,293 | 3,091 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $18,472 | 33 | Shares | Sole | 2022-07-29 | |
| No filing history on record for this holder in this stock. | ||||||